⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RGNX News
REGENXBIO Inc.
REGENXBIO to Participate in Upcoming Investor Conferences
prnewswire.com
RGNX
REGENXBIO Announces Presentation at the American Academy of Ophthalmology 2025 Annual Meeting
prnewswire.com
RGNX
REGENXBIO Announces Completion of Enrollment in Pivotal Trials of Subretinal Surabgene Lomparvovec for Wet AMD
prnewswire.com
RGNX
REGENXBIO Announces Presentation at the World Muscle Society
prnewswire.com
RGNX
REGENXBIO Presents Positive Twelve-Month Pivotal Data from Phase I/II/III CAMPSIITE® Trial of RGX-121 for Treatment of MPS II
prnewswire.com
RGNX